ProQR Therapeutics (PRQR) Shares Outstanding (Diluted Average) (2022 - 2025)

ProQR Therapeutics' Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $92.0 million for Q4 2024.

  • For Q4 2024, Shares Outstanding (Diluted Average) rose 5.54% year-over-year to $92.0 million; the TTM value through Dec 2024 reached $92.0 million, up 5.54%, while the annual FY2024 figure was $93.2 million, 6.33% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2024 was $92.0 million at ProQR Therapeutics, up from $87.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $92.0 million in Q4 2024 and bottomed at $73.1 million in Q4 2022.
  • The 3-year median for Shares Outstanding (Diluted Average) is $87.2 million (2023), against an average of $84.1 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) increased 19.25% in 2023 before it increased 5.54% in 2024.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $73.1 million in 2022, then rose by 19.25% to $87.2 million in 2023, then increased by 5.54% to $92.0 million in 2024.
  • Per Business Quant, the three most recent readings for PRQR's Shares Outstanding (Diluted Average) are $92.0 million (Q4 2024), $87.2 million (Q4 2023), and $73.1 million (Q4 2022).